Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05612555
Other study ID # 7531
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 9, 2019
Est. completion date September 9, 2020

Study information

Verified date December 2023
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The frailty syndrome is important to consider in perioperative cardiac assistance. One of its components is the patient's sarcopenia. This can be assessed by measuring the size of the psoas muscle. For this purpose, one of the most studied measures seems to be the measurement of the Psoas Index. This is a contouring of the psoas muscle, performed on an axial section of a CT scan, at the level of the L4 vertebra, which is then matched to the body surface. However, there is no standardization of measurements and volume acquisitions, and different image processing is also described. A radiological evaluation of the psoas could overcome this difficulty and provide a rapid and available screening tool for sarcopenia.


Recruitment information / eligibility

Status Completed
Enrollment 65
Est. completion date September 9, 2020
Est. primary completion date July 9, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Major subject ((=18 years old) - Subject who underwent surgery for placement of a ventricular assist device between 01/02/2014 and 30/06/2018 - Subject who has not expressed opposition to the reuse of his or her data for research purposes Exclusion Criteria: - Subject having expressed opposition to participate in the study - Absence of CT scan available at the time of implantation or CT scans older than one year prior to surgery and those older than 72 hours postoperatively - No anthropometric data available - Subject under legal protection - Subject under guardianship or curatorship

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Service de Réanimation Chirurgicale - CHU de Strasbourg - France Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Impact of sarcopenia, measured by the Psoas Index, on 28-day survival in patients undergoing cardiac assistance surgery Survival at 28 days after surgery
See also
  Status Clinical Trial Phase
Completed NCT04526964 - Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3 N/A
Completed NCT04234230 - Improved Self-management for Patients on Ventricular Assist Device (VAD)
Completed NCT03843021 - Ventricular Assist Device (VAD) Infection Prevention Survey
Recruiting NCT04613401 - Influence of Telemonitoring on the Management of LVAD-patients
Not yet recruiting NCT06087575 - Early Feasibility Study of the Supira System in Patients Undergoing HRPCI N/A